Qiagen Analyst Price Targets - Benzinga

Qiagen NV

QGENNYSE

Trade with Public

Trade with Public

$50.22

-0.12-0.24%

Últ. Act.: Oct 30, 4:01 PM

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Dividendos Comparar Opciones Informe de acciones

© 2026 Benzinga | All Rights Reserved

Qiagen Analyst Price Targets - Benzinga

Qiagen Analyst Price Targets

Wall Street analyst price targets and consensus rating for Qiagen (QGEN).

Price Target Range — 13 Quarters

Analyst Consensus — 14 Analysts

7Buy

7Hold

Consensus RatingNeutral# Analysts14Avg. Consensus PT$47Upside to Avg. PT-5.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 28, 2026	Barclays	Luke Sergott	Downgrade	Overweight→Equal-Weight	$55→$53
Oct 26, 2026	Citigroup	Albert Hu	PT Raise	Neutral	$45→$52
Oct 22, 2026	JP Morgan	Casey Woodring	Downgrade	Overweight→Neutral	$55→$52
Oct 22, 2026	Baird	Catherine Schulte	PT Raise	Outperform	$50→$52
Oct 14, 2026	JP Morgan	Casey Woodring	PT Raise	Overweight	$50→$55
Oct 6, 2026	Barclays	Luke Sergott	Upgrade	Equal-Weight→Overweight	$40→$55
Sep 9, 2026	UBS	Dan Leonard	PT Cut	Neutral	$52→$47
Aug 10, 2026	Citigroup	Brendan Digan	PT Raise	Neutral	$38→$45
Aug 7, 2026	Barclays	Luke Sergott	PT Raise	Equal-Weight	$38→$40
Aug 7, 2026	JP Morgan	Casey Woodring	PT Raise	Overweight	$45→$50
Jun 23, 2026	Morgan Stanley	Steve Beuchaw	Upgrade	Equal-Weight→Overweight	$40→$42
May 18, 2026	Stifel	Daniel Arias	PT Cut	Hold	$50→$36
May 7, 2026	TD Cowen	Dan Brennan	PT Cut	Hold	$46→$40
Apr 29, 2026	JP Morgan	Casey Woodring	PT Cut	Overweight	$60→$45
Apr 29, 2026	Citigroup	Patrick Donnelly	PT Cut	Neutral	$55→$38
Apr 29, 2026	Barclays	Luke Sergott	PT Cut	Equal-Weight	$44→$38
Apr 29, 2026	Baird	Catherine Schulte	Upgrade	Neutral→Outperform	$53→$43
Apr 14, 2026	Barclays	Luke Sergott	Downgrade	Overweight→Equal-Weight	$44
Mar 13, 2026	Deutsche Bank	Jan Koch	Upgrade	Hold→Buy	$54
Feb 6, 2026	JP Morgan	Casey Woodring	PT Raise	Overweight	$55→$60

Analyst Ratings News

PRO
Barclays Downgrades Qiagen to Equal-Weight, Lowers Price Target to $53

Barclays analyst Luke Sergott downgrades Qiagen (NYSE:QGEN) from Overweight to Equal-Weight and lowers the price target from $55 to $53.

Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on Qiagen, Raises Price Target to $52

Citigroup analyst Albert Hu maintains Qiagen (NYSE:QGEN) with a Neutral and raises the price target from $45 to $52.

Benzinga Newsdesk

This Qiagen Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday

Analysts downgraded Qiagen, Alcoa and Dutch Bros, cutting price targets for Qiagen to $52 and Dutch Bros to $46.

Avi Kapoor

PRO
JP Morgan Downgrades Qiagen to Neutral, Lowers Price Target to $52

JP Morgan analyst Casey Woodring downgrades Qiagen (NYSE:QGEN) from Overweight to Neutral and lowers the price target from $55 to $52.

Benzinga Newsdesk

PRO
Baird Maintains Outperform on Qiagen, Raises Price Target to $52

Baird analyst Catherine Schulte maintains Qiagen (NYSE:QGEN) with a Outperform and raises the price target from $50 to $52.

Benzinga Newsdesk

PRO
Barclays Upgrades Qiagen to Overweight, Raises Price Target to $55

Barclays analyst Luke Sergott upgrades Qiagen (NYSE:QGEN) from Equal-Weight to Overweight and raises the price target from $40 to $55.

Benzinga Newsdesk